NRG-103 Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

Zhongnan Hospital1
Neuregen Therapeutics Co., Ltd.1

Indications

Cancer2
High Grade Glioma (III or IV)1
HGG1
Glioblastoma (GBM)1
High Grade Glioma1

Other2 trials

A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma

Phase 1

Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.